The objective of the ProMRI Study (Phase B) is to demonstrate the clinical safety of the ProMRI Pacemaker System when used under specific MRI conditions without scan exclusion zone.
Inclusion Criteria:
The following initial inclusion criteria must be met for a subject to be enrolled and considered for the MRI-procedure:
At the pre-MRI procedure, the following procedure-related criteria must be met for the subject to undergo the MRI scan:
Absence of phrenic nerve stimulation at 4.8V @ 1.0 ms
•|pacing threshold at Pre-MRI follow-up - pacing threshold at baseline| ≤ 0.5 V
All pacing thresholds are measureable and are ≤ 2.0 V @ 0.4 ms
The pacemaker system has been implanted for at least 6 weeks.
Subject did not have a pacemaker or lead explant, exchange or reposition in the previous 6 weeks.
All lead impedances are between 200 and 1500 ohm.
Battery status is at least 30% of capacity
Exclusion Criteria:
Enrolled in any other clinical study
For pacemaker systems that include an atrial lead, subjects with either
Life expectancy of less than three months
Pregnancy
Cardiac surgery expected in the next three months
Implanted with other medical devices that may interact with MRI, such as: